William L. Davis

More information... About Experience Recognition Insights Activities and Affiliations Areas of focus Education Admissions and qualifications Will provides comprehensive legal representation to companies across a wide array of corporate and transactional matters. His expertise spans securities offerings, compliance with US Securities and Exchange Commission reporting obligations, mergers and acquisitions, corporate governance, restructurings, venture capital financings, and general corporate and securities law matters. With significant experience in cross-border, multijurisdictional transactions, Will adeptly handles mergers, acquisitions, joint ventures and re-domestication deals. He represents companies, including both domestic and international issuers, and transactions across diverse industries, including energy and life sciences. In the realm of securities transactions, Will excels in representing issuers and underwriters in various registered and private offerings of debt and equity securities. His experience encompasses convertible and straight debt offerings, initial public offerings, and secondary and follow-on equity offerings. Experience Mergers and Acquisitions NYSE-listed oil company: Represented in a Latin American joint venture and related transactions. NYSE-listed oil company: Represented an NYSE-listed refiner in its USD 475 million acquisition of Peruvian petrochemical tanks and related real estate. Texas-based academic health science center: Represented in numerous private equity joint ventures and similar arrangements involving various healthcare-related initiatives in US and non-US jurisdictions. Multiple healthcare companies: Represented various local initiatives in non-US jurisdictions, including consulting, medical device and non-profit initiatives. Stock exchange-listed companies: Represented in multi-jurisdictional entity rationalization and restructuring projects (with projects involving up to 45 countries). NYSE-listed heavy equipment company: Represented in connection with its USD 250 million purchase of a US material handling equipment dealer. French advanced-technology battery solutions company: Represented in its acquisition of a US private company. Private human resources company: Represented in its USD 230 million divestiture to a Texas-based investment firm. Texas-based health system: Represented in its USD 125 million divestiture of diagnostic laboratories to a NYSE-listed company. Texas-based academic health science center: Represented in its USD 175 million divestiture of microbiome subsidiary to an NYSE-listed company. Texas-based academic health science center: Represented in its joint venture with a Japanese publicly-listed healthcare corporation (valued at USD 350 million). NASDAQ-listed company: Represented in its re-domestication from Delaware to the UK (valued at USD 1.8 billion). NYSE-listed company: Represented in its EUR 690 million acquisition of a Spanish company with multi-jurisdictional operations. Capital Markets and Public Company Advisory NYSE-listed foodservice company: Represented in its $1 billion registered offering of senior notes. NYSE-listed marine service company: Represented in its at-the-market (ATM) offering for up to USD 30 million. NYSE-listed manufacturer of simulation technologies: Represented in its USD 250 million registered offering of common shares. NYSE-listed marine service company: Represented in its private placement and Regulation S offering of Nordic bonds. NYSE-listed oilfield services company: Represented in its USD 1.3 billion registered offering of senior notes. Publicly listed companies: Represented in multiple PIPE transactions in connection with acquisitions of private companies. NYSE-listed company: Represented in its concurrent USD 1.4 billion registered offering of senior notes and USD 700 million tender offer for senior notes. ASX-listed energy company: Represented in its US initial public offering. Publicly listed companies: Represented in the filing of omnibus and other shelf registration statements. Publicly listed companies: Represent in all aspects of their compliance with US securities laws and the listing requirements of the major US exchanges, including with respect to: Exchange Act filings, e.g., Forms 10-K, 10-Q, 8-K and proxy statements; earnings releases and presentations; Rule 10b5-1/10b-18 plans; stockholder proposals; insider trading policies and practices; NYSE/NASDAQ governance requirements board committee charters and practices; codes of conduct and other governance policies; materiality and disclosure determinations; and Section 16 and Schedule 13D/13G filings. Recognition Acritas Star, 2019-2021 Insights Not so risky business - How to increase transaction closing certainty, Bloomberg Law, September 22, 2020 Activities and Affiliations Memberships Association of Corporate Counsel Society of Corporate Secretaries and Governance Professionals Houston Bar Association